Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Crich

Showing results (251-260 of 272) with videos related to

Pageof 28
Sort By:
The Prostate|October 31, 2023
Inhibition of N-myristoyltransferase activity promotes androgen receptor degradation in prostate cancerOmar Awad Alsaidan, Emmanuel Onobun, Chenming Ye, et al.
Journal of Medicinal Chemistry|September 23, 2024
Computationally Driven Discovery of a BCR-ABL1 Kinase Inhibitor with Activity in Multidrug-Resistant Chronic Myeloid LeukemiaJarvis Hill, R Houston Givhan, Bin Yi, et al.
ACS Infectious Diseases|August 23, 2019
Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target SelectivityGirish C Sati, Vikram A Sarpe, Takayuki Furukawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2003
Branched aliphatic alkanes with quaternary substituted carbon atoms in modern and ancient geologic samplesFabien Kenig, Dirk-Jan H Simons, David Crich, et al.
Chemmedchem|April 6, 2022
Structure-Activity Relationships for 5'' Modifications of 4,5-Aminoglycoside AntibioticsJonathan C K Quirke, Girish C Sati, Amr Sonousi, et al.
ACS Infectious Diseases|September 14, 2016
Synthesis and Antiribosomal Activities of 4'-O-, 6'-O-, 4″-O-, 4',6'-O- and 4″,6″-O-Derivatives in the Kanamycin Series Indicate Differing Target Selectivity Patterns between the 4,5- and 4,6-Series of Disubstituted 2-Deoxystreptamine Aminoglycoside AntibioticsTakayuki Kato, Guanyu Yang, Youjin Teo, et al.
ACS Infectious Diseases|May 20, 2020
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like ProteaseBrendan T Freitas, Ian A Durie, Jackelyn Murray, et al.
Bioorganic & Medicinal Chemistry|July 25, 2003
Design and synthesis of highly constrained factor Xa inhibitors: amidine-substituted bis(benzoyl)--diazepan-2-ones and bis(benzylidene)-bis(gem-dimethyl)cycloketonesJian Cui, David Crich, Donald Wink, et al.
International Journal of Molecular Sciences|March 11, 2023
Identifying Drug Candidates for COVID-19 with Large-Scale Drug ScreeningYifei Wu, Scott D Pegan, David Crich, et al.
ACS Infectious Diseases|June 11, 2021
Synthesis and Antibacterial Activity of Propylamycin Derivatives Functionalized at the 5''- and Other Positions with a View to Overcoming Resistance Due to Aminoglycoside Modifying EnzymesDimitrijs Lubriks, Rimants Zogota, Vikram A Sarpe, et al.
Pageof 28

Showing results (251-260 of 272) with videos related to

Sort By:
Pageof 28
The Prostate|October 31, 2023
Inhibition of N-myristoyltransferase activity promotes androgen receptor degradation in prostate cancerOmar Awad Alsaidan, Emmanuel Onobun, Chenming Ye, et al.
Journal of Medicinal Chemistry|September 23, 2024
Computationally Driven Discovery of a BCR-ABL1 Kinase Inhibitor with Activity in Multidrug-Resistant Chronic Myeloid LeukemiaJarvis Hill, R Houston Givhan, Bin Yi, et al.
ACS Infectious Diseases|August 23, 2019
Modification at the 2'-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target SelectivityGirish C Sati, Vikram A Sarpe, Takayuki Furukawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2003
Branched aliphatic alkanes with quaternary substituted carbon atoms in modern and ancient geologic samplesFabien Kenig, Dirk-Jan H Simons, David Crich, et al.
Chemmedchem|April 6, 2022
Structure-Activity Relationships for 5'' Modifications of 4,5-Aminoglycoside AntibioticsJonathan C K Quirke, Girish C Sati, Amr Sonousi, et al.
ACS Infectious Diseases|September 14, 2016
Synthesis and Antiribosomal Activities of 4'-O-, 6'-O-, 4″-O-, 4',6'-O- and 4″,6″-O-Derivatives in the Kanamycin Series Indicate Differing Target Selectivity Patterns between the 4,5- and 4,6-Series of Disubstituted 2-Deoxystreptamine Aminoglycoside AntibioticsTakayuki Kato, Guanyu Yang, Youjin Teo, et al.
ACS Infectious Diseases|May 20, 2020
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like ProteaseBrendan T Freitas, Ian A Durie, Jackelyn Murray, et al.
Bioorganic & Medicinal Chemistry|July 25, 2003
Design and synthesis of highly constrained factor Xa inhibitors: amidine-substituted bis(benzoyl)--diazepan-2-ones and bis(benzylidene)-bis(gem-dimethyl)cycloketonesJian Cui, David Crich, Donald Wink, et al.
International Journal of Molecular Sciences|March 11, 2023
Identifying Drug Candidates for COVID-19 with Large-Scale Drug ScreeningYifei Wu, Scott D Pegan, David Crich, et al.
ACS Infectious Diseases|June 11, 2021
Synthesis and Antibacterial Activity of Propylamycin Derivatives Functionalized at the 5''- and Other Positions with a View to Overcoming Resistance Due to Aminoglycoside Modifying EnzymesDimitrijs Lubriks, Rimants Zogota, Vikram A Sarpe, et al.
Pageof 28